Abstract
P. carinii dihydrofolate reductase (PcDHFR) inhibitors are used for the treatment of P. carinii pneumonia (PCP) in humans with acquired immunodeficiency syndrome (AIDS). Translocation comparative molecular field vector analysis (Topomer CoMFA) 3D-QSAR and molecular docking were applied for a series of pyrimidine derivatives. 64 Pyrimidine derivatives were analyzed and the relationship between the structures and bioactivities was explored. Topomer CoMFA was used to build 3D-QSAR model, the results show that cross-validation q2 = 0.721, SDCV = 0.52, the non-crossvalidated r2 = 0.922, SD = 0.28, and the correlation coefficient of external validation Q2 ext = 0.934, this indicated that model generated form Topomer CoMFA was reasonable, and had good prediction ability. The mechanism of action of drug was studied by molecular docking. It showed that the pyrimidine compounds and GLU32, ILE123, LYS37 sites of PcDHFR have interactions. These results have provided an insight for the design of new potent inhibitors of PcDHFR.
Keywords: 3D-QSAR, dihydrofolate reductase, pyrimidine derivatives, topomer CoMFA, molecular docking.
Letters in Drug Design & Discovery
Title:Topomer CoMFA 3D-QSAR and Docking Studies of Pyrimidine Inhibitors of Pneumocystis Carinii Dihydrofolate Reductase
Volume: 13 Issue: 10
Author(s): Jianbo Tong, Pei Zhan, Tuanli Yao, Lanbing Ma and Min Bai
Affiliation:
Keywords: 3D-QSAR, dihydrofolate reductase, pyrimidine derivatives, topomer CoMFA, molecular docking.
Abstract: P. carinii dihydrofolate reductase (PcDHFR) inhibitors are used for the treatment of P. carinii pneumonia (PCP) in humans with acquired immunodeficiency syndrome (AIDS). Translocation comparative molecular field vector analysis (Topomer CoMFA) 3D-QSAR and molecular docking were applied for a series of pyrimidine derivatives. 64 Pyrimidine derivatives were analyzed and the relationship between the structures and bioactivities was explored. Topomer CoMFA was used to build 3D-QSAR model, the results show that cross-validation q2 = 0.721, SDCV = 0.52, the non-crossvalidated r2 = 0.922, SD = 0.28, and the correlation coefficient of external validation Q2 ext = 0.934, this indicated that model generated form Topomer CoMFA was reasonable, and had good prediction ability. The mechanism of action of drug was studied by molecular docking. It showed that the pyrimidine compounds and GLU32, ILE123, LYS37 sites of PcDHFR have interactions. These results have provided an insight for the design of new potent inhibitors of PcDHFR.
Export Options
About this article
Cite this article as:
Tong Jianbo, Zhan Pei, Yao Tuanli, Ma Lanbing and Bai Min, Topomer CoMFA 3D-QSAR and Docking Studies of Pyrimidine Inhibitors of Pneumocystis Carinii Dihydrofolate Reductase, Letters in Drug Design & Discovery 2016; 13 (10) . https://dx.doi.org/10.2174/1570180813666160324154549
DOI https://dx.doi.org/10.2174/1570180813666160324154549 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
Call for Papers in Thematic Issues
Navigating the Frontier: Probiotics' Promising Path in Combatting Viral Respiratory Infections, Spotlight on Coronaviridae.
Probiotics, well-known for their role in gut health, show promise in preventing and managing respiratory virus infections, particularly in children and at-risk populations. However, the profound influence of novel pathogenic viral RTIs such as coronaviruses has reshaped perspectives on the potential of probiotics. Despite their potential, significant gaps remain in ...read more
![Wayfinder Image](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Synthesis of Gold Mediated Biocompatible Nanocomposite of Lactone Enriched Fraction from Sahadevi (Vernonia cinerea Lees): An Assessment of Antimalarial Potential
Current Topics in Medicinal Chemistry NAD Metabolism and Functions: A Common Therapeutic Target for Neoplastic, Metabolic and Neurodegenerative Diseases
Current Topics in Medicinal Chemistry Synthesis of [DTPA-bis(D-ser)] Chelate (DBDSC): An Approach for the Design of SPECT Radiopharmaceuticals Based on Technetium
Current Radiopharmaceuticals New Hopes in Cancer Battle - A Review of New Molecules and Treatment Strategies
Medicinal Chemistry A Comparative Study Among Various Statistical Tests Using Microarray Gene Expression Data
Current Bioinformatics A Novel Antiproliferative and Antifungal Lectin from Amaranthus viridis Linn Seeds
Protein & Peptide Letters Mitochondrial Tolerance to Drugs and Toxic Agents in Ageing and Disease
Current Drug Targets From the Deepest Sea Shelf to the Uppermost Kitchen Cabinet Shelf: The Quest for Novel TNF-α Inhibitors
Current Topics in Medicinal Chemistry AKT-pathway Inhibition in Chronic Lymphocytic Leukemia Reveals Response Relationships Defined by TCL1
Current Cancer Drug Targets Recent Advances in the Mechanisms of Action and Physiological Functions of the Retinoid-Related Orphan Receptors (RORs)
Current Drug Targets - Inflammation & Allergy Expanding Targets for a Metabolic Therapy of Cancer: L-Asparaginase
Recent Patents on Anti-Cancer Drug Discovery Hedgehog Signaling in the Normal and Neoplastic Mammary Gland
Current Drug Targets Cytochromes P450 in the Bioactivation of Chemicals
Current Topics in Medicinal Chemistry Synthetic Retinoids and Their Nuclear Receptors
Current Medicinal Chemistry - Anti-Cancer Agents Prognostic Value and Clinicopathological Differences of Bmi1 in Gastric Cancer: A Meta-analysis
Anti-Cancer Agents in Medicinal Chemistry Targeting EZH2 for Cancer Therapy: Progress and Perspective
Current Protein & Peptide Science Optimization of SUV with Changing the Dose Amount in F18-FDG PET/CT of Pediatric Lymphoma Patients
Current Radiopharmaceuticals A Practical Approach to Diagnosis and Treatment of Symptomatic Thromboembolic Events in Children with Acute Lymphoblastic Leukemia: Recommendations of the “Coagulation Defects” AIEOP Working Group
Recent Patents on Cardiovascular Drug Discovery Identification of Small Molecule Binding Sites within Proteins Using Phage Display Technology
Combinatorial Chemistry & High Throughput Screening Methotrexate: A Drug of the Future in Ulcerative Colitis?
Current Drug Targets